Companion diagnostics guidance update- public consultation - Page 1 of 3 - Therapeutic Goods Administration

Introduction

1. What is your name?

Name

2. What is your email address?

3. What is your organisation?

Organisation

4. CDx identification guide

Please provide any comments regarding the CDx identification guide

5. Companion testing plan

Please provide any comments regarding the concept of the companion testing plan

6. Case studies

Are the case studies helpful? Please provide any additional comments (if any)

7. Further feedback

If you have any further comments or feedback, please detail them below